Primrose Bio, Inc.
Biotechnology company · San Diego, California, United States
Primrose Bio, Inc. is a biotechnology company headquartered in San Diego, California, United States. Its earliest recorded incorporation is in 2013. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $4.5 million in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $15 million sold in a notice filed in 2024.
Primrose Bio at a glance
What does Primrose Bio do?
US government research funding
5 SBIR/STTR small-business research awards from US health agencies, $4.5 million in total (2018 to 2022). NIH funding came from the National Institute of General Medical Sciences, National Human Genome Research Institute, National Center for Advancing Translational Sciences.
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $15 million sold (2024).
Frequently asked questions about Primrose Bio
Where is Primrose Bio headquartered?
Primrose Bio, Inc. is headquartered in San Diego, California, United States.
What does Primrose Bio do?
Primrose Bio, Inc. is a biotechnology company.
When was Primrose Bio founded?
The earliest incorporation on record for Primrose Bio, Inc. is in 2013, according to public company registers.
Similar companies
- BioAtla, Inc.San Diego, California, United States
- Neurocrine Biosciences IncSan Diego, California, United States
- ImmunityBio, Inc.San Diego, California, United States
- Sorrento Therapeutics, Inc.San Diego, California, United States
- Protego Biopharma, Inc.San Diego, California, United States
- Tempo Therapeutics, Inc.San Diego, California, United States
- Fate Therapeutics IncSan Diego, California, United States
- ImageneBio, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences